169 related articles for article (PubMed ID: 31491003)
21. Expression of cancer stem cell markers in metastatic melanoma to the brain.
Wickremesekera AC; Brasch HD; Lee VM; Davis PF; Woon K; Johnson R; Tan ST; Itinteang T
J Clin Neurosci; 2019 Feb; 60():112-116. PubMed ID: 30626524
[TBL] [Abstract][Full Text] [Related]
22. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
[TBL] [Abstract][Full Text] [Related]
23. The Identification of Three Cancer Stem Cell Subpopulations within Moderately Differentiated Lip Squamous Cell Carcinoma.
Ram R; Brasch HD; Dunne JC; Davis PF; Tan ST; Itinteang T
Front Surg; 2017; 4():12. PubMed ID: 28321397
[TBL] [Abstract][Full Text] [Related]
24. NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades.
Freitag D; McLean AL; Simon M; Koch A; Grube S; Walter J; Kalff R; Ewald C
Mol Carcinog; 2017 Aug; 56(8):1953-1964. PubMed ID: 28345785
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.
Yu HH; Featherston T; Tan ST; Chibnall AM; Brasch HD; Davis PF; Itinteang T
Front Surg; 2016; 3():46. PubMed ID: 27532037
[TBL] [Abstract][Full Text] [Related]
26. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
[TBL] [Abstract][Full Text] [Related]
27. Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors.
Munro MJ; Peng L; Wickremesekera SK; Tan ST
PLoS One; 2021; 16(8):e0256280. PubMed ID: 34428252
[TBL] [Abstract][Full Text] [Related]
28. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
29. Expression of Embryonic Stem Cell Markers on the Microvessels of WHO Grade I Meningioma.
Shivapathasundram G; Wickremesekera AC; Brasch HD; Marsh R; Tan ST; Itinteang T
Front Surg; 2018; 5():65. PubMed ID: 30417000
[No Abstract] [Full Text] [Related]
30. Expression and prognostic significance of Oct4 and Nanog in neuroblastoma.
Monajemzadeh M; Soleimani V; Vasei M; Koochakzadeh L; Karbakhsh M
APMIS; 2014 Sep; 122(9):734-41. PubMed ID: 24320714
[TBL] [Abstract][Full Text] [Related]
31. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
32. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells.
Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E; Givol D
Acta Histochem; 2013 May; 115(4):320-9. PubMed ID: 23098761
[TBL] [Abstract][Full Text] [Related]
33. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
34. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
35. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
36. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
37. Cancer Stem Cells in Glioblastoma Multiforme.
Bradshaw A; Wickremesekera A; Brasch HD; Chibnall AM; Davis PF; Tan ST; Itinteang T
Front Surg; 2016; 3():48. PubMed ID: 27617262
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells in colorectal cancer: a review.
Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
